Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1989 3
1990 3
1991 2
1995 1
1998 1
1999 1
2000 1
2001 3
2002 2
2003 3
2004 4
2005 1
2006 3
2007 5
2008 2
2009 2
2010 1
2011 1
2012 2
2013 1
2014 2
2015 3
2016 1
2019 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
[Genetic aspects of pancreatic cancer].
Grigor'eva IN, Efimova OV, Suvorova TS, Tov NL. Grigor'eva IN, et al. Among authors: tov nl. Eksp Klin Gastroenterol. 2014;(10):70-6. Eksp Klin Gastroenterol. 2014. PMID: 25911935 Review. Russian.
Therapeutic Application of Alpha-1 Antitrypsin in COVID-19.
Ritzmann F, Chitirala P, Krüger N, Hoffmann M, Zuo W, Lammert F, Smola S, Tov N, Alagem N, Lepper PM, Pöhlmann S, Beisswenger C, Herr C, Bals R; AAT-in-COVID-19 Study Group. Ritzmann F, et al. Among authors: tov n. Am J Respir Crit Care Med. 2021 Jul 15;204(2):224-227. doi: 10.1164/rccm.202104-0833LE. Am J Respir Crit Care Med. 2021. PMID: 33961754 Free PMC article. No abstract available.
Pregnancy exacerbating hepatopulmonary syndrome.
Sammour RN, Zuckerman E, Tov N, Gonen R. Sammour RN, et al. Among authors: tov n. Obstet Gynecol. 2006 Feb;107(2 Pt 2):455-7. doi: 10.1097/01.AOG.0000164055.56300.ee. Obstet Gynecol. 2006. PMID: 16449147
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD.
Stolk J, Tov N, Chapman KR, Fernandez P, MacNee W, Hopkinson NS, Piitulainen E, Seersholm N, Vogelmeier CF, Bals R, McElvaney G, Stockley RA. Stolk J, et al. Among authors: tov n. Eur Respir J. 2019 Nov 21;54(5):1900673. doi: 10.1183/13993003.00673-2019. Print 2019 Nov. Eur Respir J. 2019. PMID: 31467115 Free article. Clinical Trial.
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes.
Lebenthal Y, Brener A, Hershkovitz E, Shehadeh N, Shalitin S, Lewis EC, Elias D, Haim A, Barash G, Loewenthal N, Zuckerman-Levin N, Stein M, Tov N, Rachmiel M. Lebenthal Y, et al. Among authors: tov n. Int J Mol Sci. 2019 Nov 29;20(23):6032. doi: 10.3390/ijms20236032. Int J Mol Sci. 2019. PMID: 31795482 Free PMC article. Clinical Trial.
52 results